Aptinyx Inc reported $-15303000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
Biogen BIIB:US USD 1.13B 76.7M
Cara Therapeutics CARA:US USD -23180000 18.97M
Daiichi Sankyo 4568:JP JPY 39.46B 20.6B
Eli Lilly And LLY:US USD 1.45B 499.2M
Halozyme Therapeutics HALO:US USD 61.63M 38.95M
Intra Cellular Therapies ITCI:US USD -53508000 33.1M
IONIS PHARMACEUT IONS:US USD -46992000 58.14M
Marinus Pharmaceuticals MRNS:US USD 73.29M 112.72M
Neurocrine Biosciences NBIX:US USD 68.5M 85.4M
Novartis NOVN:VX USD 1.57B 121M
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M